We are live on ! Find out more

230 hedge funds and large institutions have $1.34B invested in CRH in 2022 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 71 increasing their positions, 78 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

9,044% more call options, than puts

Call options by funds: $15.5M | Put options by funds: $169K

70% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 23

6% more funds holding

Funds holding: 218230 (+12)

0.47% more ownership

Funds ownership: 4.58%5.05% (+0.47%)

5% less capital invested

Capital invested by funds: $1.41B → $1.34B (-$70M)

9% less repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 78

Holders
230
Holders Change
+12
Holders Change %
+5.5%
% of All Funds
3.86%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
39
Increased
71
Reduced
78
Closed
23
Calls
$15.5M
Puts
$169K
Net Calls
+$15.3M
Net Calls Change
+$342K

CRH Hedge Fund Activity: Q2 2022 in Review

230 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in CRH (CRH) for Q2 2022, worth a combined $1.34B — down 5% from $1.41B a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new CRH positions and 23 closed out — a net gain of 16 holders — while 71 added to existing stakes and 78 trimmed.

The largest buyer was Boston Partners, adding an estimated $54.5M. The largest seller was Grantham, Mayo, Van Otterloo & Co (GMO), cutting an estimated $15.2M.

  • 230 institutional investors held CRH (CRH) as of Q2 2022, up from 218 in Q1 2022.
  • Funds reported $1.34B of CRH stock for Q2 2022, down 5% quarter-over-quarter.
  • 39 funds opened new CRH positions in Q2 2022 and 23 closed out, a net change of +16 holders.
  • The largest CRH buyer in Q2 2022 was Boston Partners, an estimated $54.5M added.
  • The largest CRH seller in Q2 2022 was Grantham, Mayo, Van Otterloo & Co (GMO), an estimated $15.2M sold.

Based on aggregated 13F filings for Q2 2022.